Literature DB >> 16729718

The modulatory role of melatonin on immune responsiveness.

Antonio Carrillo-Vico1, Russel J Reiter, Patricia J Lardone, Juan Luis Herrera, Rafael Fernández-Montesinos, Juan Miguel Guerrero, David Pozo.   

Abstract

Afterhe successful discovery of the melatonin molecule by Aaron B Lerner et al at Yale University in 1958, melatonin and the pineal gland, a tiny endocrine gland situated at the center of the human brain, have primarily been considered in terms of their effects on the endocrine and reproductive systems. During the last decade, a substantial body of research has defined melatonin as a remarkable molecule with pleiotropic effects on the immune system. Moreover, its synthesis cannot be considered as exclusively endocrine; key immunocompetent cells have the functional enzymatic machinery for melatonin synthesis, paving the wayfo r complex intracrine, autocrine and paracrine regulatory loops. The immunomodulatory role of melatonin, with regard to infection, inflammation and autoimmunity, is outlined here, and the evidence discussed in this review strengthens the notion that the nature of an immune response may be modified, and therefore therapeutically manipulated, by circadian effector signals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729718

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  43 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Sleep disorders and inflammatory disease activity: chicken or the egg?

Authors:  Parth J Parekh; Edward C Oldfield Iv; Vaishnavi Challapallisri; J Catsby Ware; David A Johnson
Journal:  Am J Gastroenterol       Date:  2014-08-26       Impact factor: 10.864

3.  Melatonin as an adjuvant therapy in patients with rheumatoid arthritis.

Authors:  Ahmet Korkmaz
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

4.  Blocking of melatonin synthesis and MT(1) receptor impairs the activation of Jurkat T cells.

Authors:  Patricia J Lardone; Amalia Rubio; Isabel Cerrillo; Araceli Gómez-Corvera; Antonio Carrillo-Vico; Marina Sanchez-Hidalgo; Juan M Guerrero; Patricia Fernandez-Riejos; Victor Sanchez-Margalet; Patrocinio Molinero
Journal:  Cell Mol Life Sci       Date:  2010-05-04       Impact factor: 9.261

5.  Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats.

Authors:  Ilijana Grigorov; Desanka Bogojević; Sofija Jovanović; Anja Petrović; Svetlana Ivanović-Matić; Lidija Zolotarevski; Goran Poznanović; Vesna Martinović
Journal:  J Physiol Biochem       Date:  2014-03-07       Impact factor: 4.158

Review 6.  Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review.

Authors:  Laura B Samuelsson; Dana H Bovbjerg; Kathryn A Roecklein; Martica H Hall
Journal:  Neurosci Biobehav Rev       Date:  2017-10-13       Impact factor: 8.989

Review 7.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

Review 8.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

Review 9.  Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation.

Authors:  James E Fildes; Nizar Yonan; Brian G Keevil
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

10.  Protective effect of melatonin against mitomycin C-induced genotoxic damage in peripheral blood of rats.

Authors:  S Ortega-Gutiérrez; M López-Vicente; F Lostalé; L Fuentes-Broto; E Martínez-Ballarín; J J García
Journal:  J Biomed Biotechnol       Date:  2009-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.